Ecovyst Beats Q2 Estimates, Lifts 2026 Sales View to $1.02B-$1.06B
ECVT sits 75% above its 52-week low of $7.41.
Summary
Ecovyst delivered a strong Q2, with sales jumping 42% year-over-year to $250 million, beating the $237.48 million consensus. Adjusted EPS of $0.21 and adjusted EBITDA of $53.1 million also topped estimates. The company raised its full-year 2026 guidance, now expecting sales of $1.02 billion to $1.06 billion, up from $890 million to $970 million, and adjusted EBITDA of $195 million to $207 million, up from $180 million to $195 million. The Calabrian acquisition, completed in June, contributed to the top line and expands the company's reach into mining, water treatment, and other end markets. Management flagged lower virgin sulfuric acid spot sales in the second half, but the raised outlook signals confidence in sustained demand for regenerated acid and pricing power. This follows a pattern of guidance increases after strong Q1 results and the Calabrian deal closing.
At the time of this announcement, ECVT was trading at $13.00 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $7.41 to $15.09. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.